ChemLifeIntel
Access
ChemLifeIntel/Companies/Bryant Ranch Prepack, Inc.

Bryant Ranch Prepack, Inc.

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
2
Intelligence Briefs
0
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 2 of 2 briefs on Bryant Ranch Prepack, Inc.
REGULATORY INTELLIGENCE·Recall

Bryant Ranch Prepack Initiates Class III Recall of Cephalexin Oral Suspension Due to Labeling Error

Bryant Ranch Prepack, Inc. has initiated a Class III recall (D-0539-2024) for 190 bottles of Cephalexin for Oral Suspension, USP, due to a minor labeling discrepancy. This voluntary action, impacting nationwide distribution, underscores the critical need for meticulous quality control in pharmaceutical relabeling operations and highlights potential supply chain vulnerabilities for procurement and regulatory teams.

90-Day Activity
Bryant Ranch Prepack,Cephalexin
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2024-06-12
REGULATORY INTELLIGENCE·Recall

Bryant Ranch Prepack Initiates Class III Recall of Cephalexin Oral Suspension Due to Critical Labeling Error

Bryant Ranch Prepack, Inc. has initiated a Class III nationwide recall (D-0538-2024) for 104 bottles of Cephalexin for Oral Suspension, USP, 250mg/5mL. This action stems from a critical labeling error where the back label incorrectly stated 5g of cephalexin monohydrate instead of the correct 10g per bottle. This event underscores the imperative for rigorous quality control in pharmaceutical relabeling operations.

90-Day Activity
Bryant Ranch Prepack,Cephalexin
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
2024-06-12